Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.
Published
Journal Article
In an open-label study, 12 patients with refractory MG or who were taking only corticosteroids and required additional immunosuppression received mycophenolate mofetil 1 g twice daily for 6 months. A reduction of three points in a quantified MG score and two points in a manual muscle test or a reduction of 50% in corticosteroid dose defined efficacy. Eight patients improved, beginning after 2 weeks to 2 months. No major side effects were observed.
Full Text
Duke Authors
Cited Authors
- Ciafaloni, E; Massey, JM; Tucker-Lipscomb, B; Sanders, DB
Published Date
- January 9, 2001
Published In
Volume / Issue
- 56 / 1
Start / End Page
- 97 - 99
PubMed ID
- 11148243
Pubmed Central ID
- 11148243
International Standard Serial Number (ISSN)
- 0028-3878
Digital Object Identifier (DOI)
- 10.1212/wnl.56.1.97
Language
- eng
Conference Location
- United States